Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Int J Dev Neurosci ; 82(8): 736-747, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35943861

ABSTRACT

INTRODUCTION: MEGDEL syndrome is a rare recessive disorder, with about 100 cases reported worldwide, which is defined by 3-methylglutaconic aciduria (MEG), deafness (D), encephalopathy (E) and Leigh-like syndrome (L). When these manifestations were added to hepatopathy (H), the syndrome was labelled as MEGD(H)EL. Mutations in SERAC1 gene encoding a serine active site containing 1 protein were described in patients affected by this syndrome. PATIENTS AND METHODS: The present study reports the Whole Exome Sequencing (WES) of the first case of MEGDEHL syndrome in Tunisia in a consanguineous family with three affected children. Bioinformatic analysis was also performed in addition to mtDNA deletion screening and mtDNA copy number quantification in the blood of the indexed case, carried out, respectively by Long-Range PCR and qPCR. RESULTS: The WES revealed a novel homozygous nonsense mutation (c.1379G > A; p.W460X) in the SERAC1 gene, which was confirmed by Sanger sequencing. This nonsense mutation was present at a homozygous state in the three affected children and was heterozygous in the parents. In silico analysis using various softwares was performed, and the predictive results supported the pathogenic effect of the identified mutation. Further, long-range PCR and qPCR analyses of the patient's blood excluded any mtDNA deletions or depletions. CONCLUSION: Sequencing results and bioinformatic tools confirmed that the novel mutation (p.W460X) in the SERAC1 gene causes the severe phenotype in the studied family with MEGDEHL syndrome.


Subject(s)
Carboxylic Ester Hydrolases , Codon, Nonsense , Humans , Exome Sequencing , Pedigree , Carboxylic Ester Hydrolases/genetics , Syndrome , Mutation , DNA, Mitochondrial/genetics
2.
Neurogenetics ; 23(4): 257-270, 2022 10.
Article in English | MEDLINE | ID: mdl-35819538

ABSTRACT

Progressive encephalopathy with brain edema and/or leukoencephalopathy, PEBEL1, is a severe neurometabolic disorder characterized by rapidly progressive neurologic deterioration associated with a febrile illness. PEBEL1 is a lethal encephalopathy caused by NAXE gene mutations. Here we report a 6-month-old boy with mitochondrial encephalomyopathy from a consanguineous family. Molecular analysis was performed using whole-exome sequencing followed by segregation analysis. In addition, in silico prediction tools and molecular dynamic approaches were used to predict the structural effect of the mutation. Furthermore, molecular docking of the substrate NADP in both wild-type and mutated NAXE protein was carried out. Molecular analysis revealed the presence of the novel homozygous mutation c.641 T > A (p. Ile214Asn) in the NAXE gene, located at the NAD (P)H hydrate epimerase domain. In addition, bioinformatics analyses and molecular dynamics revealed that p. Ile214Asn mutation could affect the structure, stability, and compactness of the NAXE protein. Moreover, the result of the molecular docking showed that the p. Ile214Asn mutation leads to conformational changes in the catalytic cavity, thus modifying interaction with the substrate and restricting its access. We also compared the phenotype of our patient with those of previously reported cases with PEBEL syndrome. All bioinformatics findings provide evidence that the NAXE variant Asn214 disrupts NAXE protein functionality leading to an insufficient NAD (P)HX repair system and the development of clinical features of PEBEL1 syndrome in our patient. To our knowledge, our case is the 21st case of PEBEL1 patient worldwide and the first case in North Africa.


Subject(s)
Brain Diseases , NAD , Racemases and Epimerases , Humans , Brain Diseases/genetics , Molecular Docking Simulation , Mutation , NAD/metabolism , Pedigree , Exome Sequencing , Racemases and Epimerases/genetics , Racemases and Epimerases/metabolism
3.
Int J Dev Neurosci ; 82(7): 626-638, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35841120

ABSTRACT

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE; OMIM 603041) is a rare inherited metabolic disorder mostly caused by mutations in TYMP gene encoding thymidine phosphorylase (TP) protein that affects the mitochondrial nucleotide metabolism. TP, functionally active as a homodimer, is involved in the salvage pathway of pyrimidine nucleosides. MNGIE-like syndrome having an overlapping phenotype of MNGIE was also described and has been associated with mutations in POLG and RRM2B genes. In the present study, we report the molecular investigation of a consanguineous family including two patients with clinical features suggestive of MNGIE syndrome. Bioinformatics analyses were carried out in addition to mtDNA deletion screening and copy number quantification in the blood of the two patients. Whole exome sequencing and Sanger sequencing analyses revealed the segregation in the affected family a novel mutation c.1205T>A (p.L402Q) within the exon 9 of the TYMP gene. In addition, mtDNA analysis revealed the absence of mtDNA deletions and a decrease of the copy number in the blood of the two patients of the studied family. The p.Leu402Gln mutation was located in a conserved amino acid within the α/ß domain of the TP protein and several software supported its pathogenicity. In addition, and based on docking and molecular dynamic simulation analyses, results revealed that L402Q caused a conformational change in TP mutated structure and could therefore alter its flexibility and stability. These changes prevent also the formation of stable homodimer leading to non-functional protein with partial or complete loss of its catalytic activity.


Subject(s)
Mitochondrial Encephalomyopathies , Thymidine Phosphorylase , Humans , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Mitochondrial Encephalomyopathies/genetics , Molecular Docking Simulation , Mutation , Thymidine/metabolism , Thymidine Phosphorylase/genetics , Thymidine Phosphorylase/metabolism , Pedigree , Male , Female
4.
Mol Biol Rep ; 48(5): 4373-4382, 2021 May.
Article in English | MEDLINE | ID: mdl-34089464

ABSTRACT

Mitochondrial diseases include a wide group of clinically heterogeneous disorders caused by a dysfunction of the mitochondrial respiratory chain and can be related to mutations in nuclear or mitochondrial DNA genes. In the present report, we performed a whole mitochondrial genome screening in two patients with clinical features of mitochondrial diseases. Mutational analysis revealed the presence of two undescribed heteroplasmic mitochondrial variations, the m.3911A > G (E202G) variant in the MT-ND1 gene found in two patients (P1 and P2) and the m.12058A > C (E433D) pathogenic variant in the MT-ND4 gene present only in patient P2 who had a more severe phenotype. These two substitutions were predicted to be damaging by several bioinformatics tools and lead to amino acid changes in two conserved residues localized in two important functional domains of the mitochondrial subunits of complex I. Furthermore, the 3D modeling suggested that the two amino acid changes could therefore alter the structure of the two subunits and may decrease the stability and the function of complex I. The two described pathogenic variants found in patient P2 could act synergically and alter the complex I function by affecting the proton pumping processes and the energy production and then could explain the severe phenotype compared to patient P1 presenting only the E202G substitution in ND1.


Subject(s)
Computational Biology/methods , Genes, Mitochondrial , Mitochondrial Diseases/genetics , NADH Dehydrogenase/genetics , Phenotype , Polymorphism, Single Nucleotide , Child , DNA Mutational Analysis/methods , DNA, Mitochondrial/genetics , Female , Genetic Predisposition to Disease/genetics , Genome, Mitochondrial , Humans , Mutation, Missense
5.
Acta Neurol Belg ; 121(6): 1733-1740, 2021 Dec.
Article in English | MEDLINE | ID: mdl-32979145

ABSTRACT

Ataxia with isolated vitamin E deficiency (AVED) is a rare autosomal recessive cerebellar ataxia disorder that is caused by a mutation in the alpha-tocopherol transfer protein gene TTPA, leading to a lower level of serum vitamin E. Although it is almost clinically similar to Friedreich's ataxia, its devastating neurological features can be prevented with appropriate treatment. In this study, we present a patient who was initially diagnosed with Friedreich's ataxia, but was later found to have AVED. Frataxin gene screening revealed the absence of GAA expansion in homozygous or heterozygous state. However, TTPAgene sequencing showed the presence of the c.744delA mutation, leading to a premature stop codon (p.E249fx). In addition, the result of mutational analysis of MT-DNA genes revealed the presence of several variants, including the m.10044A>G mutation in MT-TG gene. Here, we report for the first time the coexistence of both mitochondrial and nuclear genes mutations in AVED.


Subject(s)
Ataxia/diagnosis , Ataxia/genetics , DNA Mutational Analysis/methods , DNA, Mitochondrial/genetics , Mutation/genetics , Vitamin E Deficiency/diagnosis , Vitamin E Deficiency/genetics , Base Sequence , Female , Humans , Pedigree , Young Adult
6.
Mol Biol Rep ; 47(5): 3779-3787, 2020 May.
Article in English | MEDLINE | ID: mdl-32319008

ABSTRACT

Mitochondrial diseases are a clinically heterogeneous group of multisystemic disorders that arise as a result of various mitochondrial dysfunctions. Autosomal recessive aARS deficiencies represent a rapidly growing group of severe rare inherited mitochondrial diseases, involving multiple organs, and currently without curative option. They might be related to defects of mitochondrial aminoacyl t-RNA synthetases (mtARS) that are ubiquitous enzymes involved in mitochondrial aminoacylation and the translation process. Here, using NGS analysis of 281 nuclear genes encoding mitochondrial proteins, we identified 4 variants in different mtARS in three patients from unrelated Tunisian families, with clinical features of mitochondrial disorders. Two homozygous variants were found in KARS (c.683C>T) and AARS2 (c.1150-4C>G), respectively in two patients, while two heterozygous variants in EARS2 (c.486-7C>G) and DARS2 (c.1456C>T) were concomitantly found in the third patient. Bio-informatics investigations predicted their pathogenicity and deleterious effects on pre-mRNA splicing and on protein stability. Thus, our results suggest that mtARS mutations are common in Tunisian patients with mitochondrial diseases.


Subject(s)
Alanine-tRNA Ligase/genetics , Mitochondrial Diseases/genetics , Mitochondrial Proteins/genetics , Alanine-tRNA Ligase/metabolism , Amino Acyl-tRNA Synthetases/genetics , Amino Acyl-tRNA Synthetases/metabolism , Aspartate-tRNA Ligase/genetics , Aspartate-tRNA Ligase/metabolism , Child , Child, Preschool , Female , Genetic Association Studies , High-Throughput Nucleotide Sequencing/methods , Homozygote , Humans , Male , Mitochondria/metabolism , Mitochondrial Diseases/metabolism , Mitochondrial Proteins/metabolism , Mutation/genetics , Pedigree
7.
Ann Hum Genet ; 82(6): 457-468, 2018 11.
Article in English | MEDLINE | ID: mdl-30079523

ABSTRACT

The multiple drug resistance 3 (MDR3) protein is a canalicular phospholipid translocator involved in the bile secretion and encoded by the ABCB4 gene. Its deficiency is related to a large spectrum of liver diseases. Taking into account the increased evidence about the involvement of synonymous variants in inherited diseases, this study aims to explore the putative effects of silent genetic variants on the ABCB4 expression. We performed an exhaustive computational approach using ESE finder, RegRNA 2.0, MFOLD, SNPfold, and %MinMax software added to the measurement of the Relative Synonymous Codon Usage. This analysis included 216 synonymous variants distributed throughout the ABCB4 gene. Results have shown that 11 synonymous coding SNPs decrease the ESE activity, while 8 of them change the codon frequency. Besides, the c.24C>T variation, located 21 nucleotides downstream the start A (Adenine) U (Uracil) G (Glutamine) AUG causes an increase in the local stability. Moreover, the computational analysis of the 3'UTR region showed that six of the eight variants located in this region affected the Wild Type (WT) pattern of the miRNA targets sites and/or their proper display. The 26 sSNPs retained as putatively functional possessed a very low allele frequency, supporting their pathogenicity. In conclusion, the obtained results suggest that some synonymous SNPs in the ABCB4 gene, considered up to now as neutral, may be involved in the MDR3 deficiency.


Subject(s)
Polymorphism, Single Nucleotide , ATP Binding Cassette Transporter, Subfamily B , Codon , Computer Simulation , Gene Frequency , Humans , Software
8.
Biochem Biophys Res Commun ; 497(4): 1049-1054, 2018 03 18.
Article in English | MEDLINE | ID: mdl-29481798

ABSTRACT

Mitochondria are essential for early cardiac development and impaired mitochondrial function was described associated with heart diseases such as hypertrophic or dilated mitochondrial cardiomyopathy. In this study, we report a family including two individuals with severe dilated mitochondrial cardiomyopathy. The whole mitochondrial genome screening showed the presence of several variations and a novel homoplasmic mutation m.4318-4322delC in the MT-TI gene shared by the two patients and their mother and leading to a disruption of the tRNAIle secondary structure. In addition, a mitochondrial depletion was present in blood leucocyte of the two affected brother whereas a de novo heteroplasmic multiple deletion in the major arc of mtDNA was present in blood leucocyte and mucosa of only one of them. These deletions in the major arc of the mtDNA resulted to the loss of several protein-encoding genes and also some tRNA genes. The mtDNA deletion and depletion could result to an impairment of the oxidative phosphorylation and energy metabolism in the respiratory chain in the studied patients. Our report is the first description of a family with severe lethal dilated mitochondrial cardiomyopathy and presenting several mtDNA abnormalities including punctual mutation, deletion and depletion.


Subject(s)
Cardiomyopathy, Dilated/genetics , DNA, Mitochondrial/genetics , Mitochondria, Heart/genetics , Mutation , RNA, Transfer, Ile/genetics , Energy Metabolism , Family , Genome, Mitochondrial/genetics , Humans , Infant , Infant, Newborn , Mitochondria/genetics , Oxidative Phosphorylation , RNA, Transfer, Ile/chemistry , Sequence Deletion
9.
Biochem Biophys Res Commun ; 497(4): 1043-1048, 2018 03 18.
Article in English | MEDLINE | ID: mdl-29481804

ABSTRACT

Leigh syndrome (LS) is a rare progressive neurodegenerative disorder occurring in infancy. The most common clinical signs reported in LS are growth retardation, optic atrophy, ataxia, psychomotor retardation, dystonia, hypotonia, seizures and respiratory disorders. The paper reported a manifestation of 3 Tunisian patients presented with LS syndrome. The aim of this study is the MT[HYPHEN]ATP6 and SURF1 gene screening in Tunisian patients affected with classical Leigh syndrome and the computational investigation of the effect of detected mutations on its structure and functions by clinical and bioinformatics analyses. After clinical investigations, three Tunisian patients were tested for mutations in both MT-ATP6 and SURF1 genes by direct sequencing followed by in silico analyses to predict the effects of sequence variation. The result of mutational analysis revealed the absence of mitochondrial mutations in MT-ATP6 gene and the presence of a known homozygous splice site mutation c.516-517delAG in sibling patients added to the presence of a novel double het mutations in LS patient (c.752-18 A > C/c. c.751 + 16G > A). In silico analyses of theses intronic variations showed that it could alters splicing processes as well as SURF1 protein translation. Leigh syndrome (LS) is a rare progressive neurodegenerative disorder occurring in infancy. The most common clinical signs reported in LS are growth retardation, optic atrophy, ataxia, psychomotor retardation, dystonia, hypotonia, seizures and respiratory disorders. The paper reported a manifestation of 3 Tunisian patients presented with LS syndrome. The aim of this study is MT-ATP6 and SURF1 genes screening in Tunisian patients affected with classical Leigh syndrome and the computational investigation of the effect of detected mutations on its structure and functions. After clinical investigations, three Tunisian patients were tested for mutations in both MT-ATP6 and SURF1 genes by direct sequencing followed by in silico analysis to predict the effects of sequence variation. The result of mutational analysis revealed the absence of mitochondrial mutations in MT-ATP6 gene and the presence of a known homozygous splice site mutation c.516-517delAG in sibling patients added to the presence of a novel double het mutations in LS patient (c.752-18 A>C/ c.751+16G>A). In silico analysis of theses intronic vaiations showed that it could alters splicing processes as well as SURF1 protein translation.


Subject(s)
Cytochrome-c Oxidase Deficiency/enzymology , Electron Transport Complex IV/metabolism , Leigh Disease/genetics , Membrane Proteins/genetics , Mitochondrial Proteins/genetics , Mitochondrial Proton-Translocating ATPases/genetics , Brain/diagnostic imaging , Child , Child, Preschool , Computer Simulation , DNA Mutational Analysis , Humans , Magnetic Resonance Imaging , Male , Mutation , RNA Splicing , Tunisia
10.
Biochem Biophys Res Commun ; 495(2): 1730-1737, 2018 01 08.
Article in English | MEDLINE | ID: mdl-29217198

ABSTRACT

Deficiency of the mitochondrial enzyme succinyl COA ligase (SUCL) is associated with encephalomyopathic mtDNA depletion syndrome and methylmalonic aciduria. This disorder is caused by mutations in both SUCL subunits genes: SUCLG1 (α subnit) and SUCLA2 (ß subnit). We report here, two Tunisian patients belonging to a consanguineous family with mitochondrial encephalomyopathy, hearing loss, lactic acidosis, hypotonia, psychomotor retardation and methylmalonic aciduria. Mutational analysis of SUCLG1 gene showed, for the first time, the presence of c.41T > C in the exon 1 at homozygous state. In-silico analysis revealed that this mutation substitutes a conserved methionine residue to a threonine at position 14 (p.M14T) located at the SUCLG1 protein mitochondrial targeting sequence. Moreover, these analysis predicted that this mutation alter stability structure and mitochondrial translocation of the protein. In Addition, a decrease in mtDNA copy number was revealed by real time PCR in the peripheral blood leukocytes in the two patients compared with controls.


Subject(s)
Mitochondrial Encephalomyopathies/enzymology , Mitochondrial Encephalomyopathies/genetics , Mutation, Missense , Succinate-CoA Ligases/deficiency , Succinate-CoA Ligases/genetics , Acidosis, Lactic/genetics , Amino Acid Metabolism, Inborn Errors/genetics , Amino Acid Substitution , Child, Preschool , Consanguinity , DNA, Mitochondrial/genetics , Enzyme Stability/genetics , Female , Gene Dosage , Hearing Loss/genetics , Homozygote , Humans , Infant , Male , Muscle Hypotonia/genetics , Succinate-CoA Ligases/chemistry
11.
Environ Sci Pollut Res Int ; 25(6): 5779-5787, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29235020

ABSTRACT

Mitochondria play an essential role to supply the cell with metabolic energy in the form of adenosine triphosphate (ATP) through oxidative phosphorylation (OXPHOS). As a consequence, they are also the primary source of cellular reactive oxygen species (ROS) which can cause oxidative damage of individual respiratory chain complexes. Indeed, affected OXPHOS subunits result in decreases in ATP production and increases in ROS formation which generate oxidative phosphorylation deficiency leading to mitochondrial dysfunctions. It has been suggested that ROS play a vital role in the pathogenesis of mitochondrial diseases. To the best of our knowledge, this is the first study which aimed to investigate the genetic variant effect of the antioxidant enzymes GSTM1 and GSTT1 on mitochondrial disease among a Tunisian population. In this report, 109 patients with mitochondrial disease and 154 healthy controls were genotyped by multiplex PCR amplification, and data were analyzed by SPSS v20 software. The results showed that GSTM1 null genotype was found to be associated with mitochondrial disease with a protective effect; however, no significant association of GSTT1 polymorphism with mitochondrial disease risk was revealed. But, interestingly, our findings highlight that GSTM1 active and GSTT1 null genotype combination increased by three fold the risk of developing mitochondrial disease with p c = 0.020, notably mitochondrial myopathy with p c = 0.046 and Leigh syndrome with p c = 0.042. In conclusion, this study suggests that GSTM1 active and GSTT1 null genotype combination might be a risk factor in developing mitochondrial disease.


Subject(s)
Genetic Predisposition to Disease , Glutathione Transferase/genetics , Mitochondrial Diseases/genetics , Polymorphism, Genetic , Adult , Case-Control Studies , Female , Genotype , Humans , Male , Middle Aged , Mitochondrial Diseases/enzymology , Multiplex Polymerase Chain Reaction , Risk Factors , Tunisia
12.
Biochem Biophys Res Commun ; 484(1): 71-78, 2017 02 26.
Article in English | MEDLINE | ID: mdl-28104394

ABSTRACT

Mitochondrial disease refers to a heterogeneous group of disorders resulting in defective cellular energy production due to dysfunction of the mitochondrial respiratory chain, which is responsible for the generation of most cellular energy. Because cardiac muscles are one of the high energy demanding tissues, mitochondrial cardiomyopathies is one of the most frequent mitochondria disorders. Mitochondrial cardiomyopathy has been associated with several point mutations of mtDNA in both genes encoded mitochondrial proteins and mitochondrial tRNA and rRNA. We reported here the first description of mutations in MT-ATP6 gene in two patients with clinical features of dilated mitochondrial cardiomyopathy. The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A>G mutation in MT-RNR1 gene associated to the m.8527A>G (p.M>V) and the m.8392C>T (p.136P>S) variations in the mitochondrial MT-ATP6 gene in patient1 and his family members with variable phenotype including hearing impairment. The second patient with isolated mitochondrial cardiomyopathy presented the m.8605C>T (p.27P>S) mutation in the MT-ATP6 gene. The three mutations p.M1V, p.P27S and p.P136S detected in MT-ATP6 affected well conserved residues of the mitochondrial protein ATPase 6. In addition, the substitution of proline residue at position 27 and 136 effect hydrophobicity and structure flexibility conformation of the protein.


Subject(s)
Cardiomyopathy, Dilated/genetics , Hearing Loss/genetics , Mitochondria, Heart/genetics , Mitochondrial Proton-Translocating ATPases/genetics , Mutation , RNA, Ribosomal/genetics , Adolescent , Amino Acid Sequence , Animals , Genome, Mitochondrial , Humans , Infant , Male , Sequence Homology, Amino Acid
13.
Comput Biol Chem ; 65: 103-109, 2016 12.
Article in English | MEDLINE | ID: mdl-27788395

ABSTRACT

Progressive Familial Intrahepatic Cholestasis type 3 (PFIC3) is an autosomal-recessive liver disease due to mutations in the ABCB4 gene encoding for the MDR3 protein. In the present study, we performed molecular and bioinformatic analyses in PFIC3 patients in order to understand the molecular basis of the disease. The three studied patients with PFIC3 were screened by PCR amplification followed by direct sequencing of the 27 coding exons of ABCB4. In silico analysis was performed by bioinformatic programs. We revealed three synonymous polymorphisms c.175C>T, c.504C>T, c.711A>T respectively in exon 4, 6, 8 and an intronic c.3487-16T>C variation in intron 26. The computational study of these polymorphic variants using Human Splicing Finder, ex-skip, Mfold and kineFold tools showed the putative impact on the composition of the cis-acting regulatory elements of splicing as well as on the mRNA structure and stability. Moreover, the protein level was affected by codon usage changes estimated by the calculation of ΔRSCU and ΔLog Ratio of codon frequencies interfering as consequence with the accurate folding of the MDR3 protein. As the first initiative of the mutational study of ABCB4 genes in Tunisia, our results are suggestive of a potential downstream molecular effect for the described polymorphisms on the expression pattern of the ABCB4 underlining the importance of synonymous variants.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B/genetics , Cholestasis, Intrahepatic/genetics , Codon , RNA Splicing , RNA Stability , RNA, Messenger/genetics , Child, Preschool , Computer Simulation , Female , Humans , Infant , Male
14.
Biochem Biophys Res Commun ; 474(4): 702-708, 2016 Jun 10.
Article in English | MEDLINE | ID: mdl-27155156

ABSTRACT

Mitochondrial diseases caused by mitochondrial dysfunction are a clinically and genetically, heterogeneous group of disorders involving multiple organs, particularly tissues with high-energy demand. Hearing loss is a recognized symptom of a number of mitochondrial diseases and can result from neuronal or cochlear dysfunction. The tissue affected in this pathology is most probably the cochlear hair cells, which are essential for hearing function since they are responsible for maintaining the ionic gradients necessary for sound signal transduction. Several mitochondrial DNA mutations have been associated with hearing loss and since mitochondria are crucial for the cellular energy supply in many tissues, most of these mtDNA mutations affect several tissues and will cause syndromic hearing loss. In the present study, we described 2 patients with sensorineural hearing loss and neurodevelopmental delay in whom we tested mitochondrial genes described to be associated with syndromic hearing loss. One of these patients showed a novel heteroplasmic mitochondrial mutation m.3861A > C (W185C) which lead to a loss of stability of the ND1 protein since it created a new hydrogen bund between the unique created cystein C185 and the A182 residue. In the second patient, we detected two novel heteroplasmic variations m.12350C > A (T5N) and m.14351T > C (E108G) respectively in the MT-ND5 and the MT-ND6 genes. The TopPred II prediction for the E108G variation revealed a decrease of the hydrophobicity in the mutated MT-ND6.


Subject(s)
DNA Mutational Analysis/methods , DNA, Mitochondrial/genetics , Genetic Testing/methods , Hearing Loss, Sensorineural/genetics , NADH Dehydrogenase/genetics , Neurodevelopmental Disorders/genetics , Child , Female , Genetic Markers/genetics , Genetic Predisposition to Disease/genetics , Humans , Male , Mitochondria/genetics , Polymorphism, Single Nucleotide/genetics
15.
Biochem Biophys Res Commun ; 473(2): 578-85, 2016 Apr 29.
Article in English | MEDLINE | ID: mdl-27033601

ABSTRACT

Mitochondrial diseases are a heterogeneous group of disorders caused by the impairment of the mitochondrial oxidative phosphorylation system which have been associated with various mutations of the mitochondrial DNA (mtDNA) and nuclear gene mutations. The clinical phenotypes are very diverse and the spectrum is still expanding. As brain and muscle are highly dependent on OXPHOS, consequently, neurological disorders and myopathy are common features of mtDNA mutations. Mutations in mtDNA can be classified into three categories: large-scale rearrangements, point mutations in tRNA or rRNA genes and point mutations in protein coding genes. In the present report, we screened mitochondrial genes of complex I, III, IV and V in 2 patients with mitochondrial neuromuscular disorders. The results showed the presence the pathogenic heteroplasmic m.9157G>A variation (A211T) in the MT-ATP6 gene in the first patient. We also reported the first case of triplication of 9 bp in the mitochondrial NC7 region in Africa and Tunisia, in association with the novel m.14924T>C in the MT-CYB gene in the second patient with mitochondrial neuromuscular disorder.


Subject(s)
DNA, Mitochondrial/genetics , Mitochondria/genetics , Mitochondrial Diseases/genetics , Neuromuscular Diseases/genetics , Amino Acid Sequence , Base Sequence , Child , Cytochromes b/chemistry , Cytochromes b/genetics , Female , Genes, Mitochondrial , Humans , Male , Mitochondria/pathology , Mitochondrial Diseases/pathology , Mitochondrial Proton-Translocating ATPases/chemistry , Mitochondrial Proton-Translocating ATPases/genetics , Molecular Sequence Data , Mutation , Neuromuscular Diseases/pathology , Point Mutation
16.
Biochem Biophys Res Commun ; 473(1): 61-66, 2016 Apr 22.
Article in English | MEDLINE | ID: mdl-26993169

ABSTRACT

Mitochondrial diseases encompass a wide variety of pathologies characterized by a dysfunction of the mitochondrial respiratory chain resulting in an energy deficiency. The respiratory chain consists of five multi-protein complexes providing coupling between nutrient oxidation and phosphorylation of ADP to ATP. In the present report, we studied mitochondrial genes of complex I, III, IV and V in 2 Tunisian patients with mitochondrial neuromuscular disorders. In the first patient, we detected the m.8392C>T variation (P136S) in the mitochondrial ATPase6 gene and the m.8527A>G transition at the junction MT-ATP6/MT-ATP8 which change the initiation codon AUG to GUG. The presence of these two variations in such an important gene could probably affect the ATP synthesis in the studied patient. In the second patient, we detected several known variations in addition to a mitochondrial deletion in the major arc of the mtDNA eliminating tRNA and respiratory chain protein genes. This deletion could be responsible of an inefficient translation leading to an inefficient mitochondrial protein synthesis in P2.


Subject(s)
Mitochondria/metabolism , Mitochondrial Diseases/genetics , Mitochondrial Proton-Translocating ATPases/genetics , Mutation , Neuromuscular Diseases/genetics , Amino Acid Sequence , Base Sequence , Child , Codon , DNA Mutational Analysis , Gene Deletion , Genetic Variation , Humans , Male , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Transfer/chemistry , Sequence Deletion , Sequence Homology, Amino Acid
17.
Biochem Biophys Res Commun ; 459(3): 353-60, 2015 Apr 10.
Article in English | MEDLINE | ID: mdl-25701779

ABSTRACT

Mitochondrial diabetes (MD) is a heterogeneous disorder characterized by a chronic hyperglycemia, maternal transmission and its association with a bilateral hearing impairment. Several studies reported mutations in mitochondrial genes as potentially pathogenic for diabetes, since mitochondrial oxidative phosphorylation plays an important role in glucose-stimulated insulin secretion from beta cells. In the present report, we studied a Tunisian family with mitochondrial diabetes (MD) and deafness associated with nephropathy. The mutational analysis screening revealed the presence of a novel heteroplasmic mutation m.9276G>C in the mitochondrial COIII gene, detected in mtDNA extracted from leukocytes of a mother and her two daughters indicating that this mutation is maternally transmitted and suggest its implication in the observed phenotype. Bioinformatic tools showed that m.9267G>C mutation (p.A21P) is « deleterious ¼ and it can modify the function and the stability of the MT-COIII protein by affecting the assembly of mitochondrial COX subunits and the translocation of protons then reducing the activity of the respective OXPHOS complexes of ATP synthesis. The nonsynonymous mutation (p.A21P) has not been reported before, it is the first mutation described in the COXIII gene which is related to insulin dependent mitochondrial diabetes and deafness and could be specific to the Tunisian population. The m.9267G>C mutation was present with a nonsynonymous inherited mitochondrial homoplasmic variation MT-COI m.5913 G>A (D4N) responsible of high blood pressure, a clinical feature detected in all explored patients.


Subject(s)
Deafness/complications , Deafness/genetics , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/genetics , Electron Transport Complex IV/genetics , Genes, Mitochondrial , Kidney Diseases/complications , Kidney Diseases/genetics , Mutation, Missense , Adult , Amino Acid Sequence , Amino Acid Substitution , Base Sequence , Case-Control Studies , Child, Preschool , DNA Mutational Analysis , DNA, Mitochondrial/genetics , Deafness/enzymology , Diabetes Mellitus, Type 2/enzymology , Electron Transport Complex IV/chemistry , Female , Humans , Hypertension/complications , Hypertension/enzymology , Hypertension/genetics , Kidney Diseases/enzymology , Male , Middle Aged , Mitochondrial Diseases , Models, Molecular , Molecular Sequence Data , Pedigree , Protein Structure, Secondary , Sequence Homology, Amino Acid , Tunisia , Young Adult
18.
Comput Biol Chem ; 54: 44-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25590135

ABSTRACT

Mutations in the SCN1A gene have commonly been associated with a wide range of mild to severe epileptic syndromes. They generate a wide spectrum of phenotypes ranging from the relatively mild generalized epilepsy with febrile seizures plus (GEFS+) to other severe epileptic encephalopathies, including myoclonic epilepsy in infancy (SMEI), cryptogenic focal epilepsy (CFE), cryptogenic generalized epilepsy (CGE) and a distinctive subgroup termed as severe infantile multifocal epilepsy (SIMFE). The present study was undertaken to investigate the potential effects of a transition in the first nucleotide at the donor splice site of intron 15 of the SCN1A gene leading to CGES. Functional analyses using site-directed mutagenesis by PCR and subsequent ex-vivo splicing assays, revealed that the c.2946+1G>T mutation lead to a total skipping of exon 15. The exclusion of this exon did not alter the reading frame but induced the deletion of the amino acids (853 Leu -971 Val) which are a major part in the fourth, fifth and sixth transmembrane segments of the SCN1A protein. The theoretical implications of the splice site mutations predicted with the bioinformatic tool human splice finder were investigated and compared with the results obtained by the cellular assay.


Subject(s)
Amino Acid Sequence , Epilepsies, Myoclonic/genetics , Introns , Mutation , NAV1.1 Voltage-Gated Sodium Channel/genetics , Sequence Deletion , Base Sequence , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Exons , Gene Expression , Humans , Molecular Sequence Data , Mutagenesis, Site-Directed , NAV1.1 Voltage-Gated Sodium Channel/chemistry , Phenotype , RNA Splice Sites , Recombinant Proteins/chemistry , Recombinant Proteins/genetics
19.
J Assist Reprod Genet ; 31(5): 595-600, 2014 May.
Article in English | MEDLINE | ID: mdl-24550096

ABSTRACT

PURPOSE: Infertility affects 10-15 % of the population, of which, approximately 40 % is due to male etiology consisting primarily of low sperm count (oligozoospermia) and/or abnormal sperm motility (asthenozoospermia). It has been demonstrated that mtDNA base substitutions can greatly influence semen quality. METHODS: In the present study we performed a systematic sequence analysis of the mitochondrial cytochrome oxidase III (COIII) gene in 31 asthenozoospermic infertile men in comparaison to normozoospermic infertile men (n=33) and fertile men (n=150) from Tunisian population. RESULTS: A novel m.9588G>A mutation was found in the mtDNA sperm's in all asthenozoospermic patients and was absent in the normozoospermic and in fertile men. The m.9588G>A mutation substitutes a highly conserved Glutamate at position 128 to Lysine. In addition, PolyPhen-2 analysis predicted that this variant is "probably damaging".


Subject(s)
Asthenozoospermia/genetics , Electron Transport Complex IV/genetics , Mutation, Missense , Amino Acid Sequence , Case-Control Studies , DNA, Mitochondrial , Electron Transport Complex IV/chemistry , Humans , Male , Molecular Sequence Data , Protein Conformation , Tunisia
20.
Mitochondrial DNA ; 25(5): 394-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-23841600

ABSTRACT

Mitochondrial DNA (mtDNA) defects were known to be associated with a large spectrum of human diseases and patients might present wide range of clinical features with various combinations. Mutations in mitochondrial tRNAs, rRNAs and protein-coding genes or large-scale rearrangements have been implicated in several cytopathies. Mitochondrial myopathies, usually maternally inherited group of neuromuscular diseases caused by mitochondrial dysfunction occurring before the age of 20 years and often begin with exercise intolerance, muscle weakness and neurodevelopmental retardation. We studied the mtDNA in three Tunisian patients with mitochondrial myopathy. The mutational analysis screening revealed the presence of two mitochondrial mutations: the m.5521G>A mutation in the D-stem region of the tRNA(Trp) gene which could lead to a disruption of the secondary structure of this tRNA and affect the tRNA-ribosome interaction with a consequent decrease in the rate of synthesis of mitochondrial proteins. The second mutation is the m.8249G>A (p.G222R) variation in the MT-CO2 gene which may affect the electrons transfer from cytochrome c to the bimetallic center of the catalytic subunit I.


Subject(s)
Cyclooxygenase 2/genetics , DNA Mutational Analysis/methods , DNA, Mitochondrial/analysis , Mitochondrial Myopathies/genetics , RNA, Transfer, Trp/genetics , Adolescent , Case-Control Studies , Child , Female , Humans , Male , Point Mutation , Tunisia
SELECTION OF CITATIONS
SEARCH DETAIL
...